EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson’s Disease

Tatiana S Usenko iD, Alena E Kopytova, Artem D Izyumchenko, Darya G Kulabukhova iD, Artemiy S Silantyev, Victoria D Kazakova iD, Katerina S Basharova iD, Anastasia I Bezrukova, Luiza A Garaeva iD, Evgeny B Pichkur, Alexandra V Artynyuk, Irina V Miliukhina und 8 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tatiana S Usenko und 19 weiteren Autor:innen. Beteiligte Einrichtung: Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre «Kurchatov Institute», Gatchina 188300, Russia. Hauptthemen laut MEDLINE: Parkinson Disease, Extracellular Vesicles, Glucosylceramidase, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease, associated with mutations in the GBA1 gene (GBA1-PD), is the most common genetic form of Parkinson’s disease (PD), marked by clinical heterogeneity influenced by mutation type. Extracellular vesicles (EVs), key mediators of intercellular communication, are implicated in PD pathogenesis through the transport of pathological proteins and lipids. In this study, we analyzed blood plasma-derived EVs from GBA1-PD patients carrying p.N370S and p.L444P mutations and from healthy controls using cryo-electron microscopy, lipidomics, and proteomics. EVs from GBA1-PD patients were significantly larger than those from controls, with the largest size and most multilayered vesicles observed in p.N370S carriers. Lipidomic profiling identified 237 lipid species; of these, 186 lipids were altered in p.N370S and 24 in p.L444P versus controls. Mutation carriers showed distinct lipid signatures, with p.L444P samples enriched predominantly in sphingolipids, while p.N370S carriers exhibited more extensive lipid remodeling across multiple classes, including triglycerides, cholesteryl esters, and phospholipids. Notably, Cer 23:0 was elevated across all GBA1-PD groups. Proteomic analysis revealed enrichment in pathways related to lipid transport, immune regulation, and vesicle-mediated processes. Overall, GBA1-PD patients share a distinct lipidomic EV signature, with mutation-specific patterns reflecting differing mechanisms of lysosomal dysfunction. These findings support the potential of EV profiling to unravel disease heterogeneity and identify biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseExtracellular VesiclesGlucosylceramidaseMutationLipidsHumansFemaleMaleMiddle AgedAgedLipidomicsProteomicsLipid MetabolismCase-Control Studies

Stichwörter der Autor:innen

GBA1Parkinson’s diseasecryo-electron microscopyextracellular vesicleslipidomicsproteomics

Substanzen

GlucosylceramidaseGBA protein, humanLipids

Autor:innen und Institutionen

  • Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre «Kurchatov Institute», Gatchina 188300, Russia.
  • Department of Molecular Genetic and Nanobiological Technologies, Pavlov First Saint Petersburg State Medical University, St. Petersburg 197022, Russia.
  • Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 143007, Russia.
  • National Research Center "Kurchatov Institute", Moscow 123098, Russia.
  • N.P. Bechtereva Institute of the Human Brain of Russian Academy of Sciences, St. Petersburg 197022, Russia.

ORCID-Profile: Tatiana S Usenko, Darya G Kulabukhova, Victoria D Kazakova, Katerina S Basharova, Luiza A Garaeva, Valentina V Miroshnikova, Stanislav N Naryzhny, Andrey L Konevega, Tatiana A Shtam

Förderung

  • Russian Science Foundation

Zitieren

APA

Usenko, T. S., Kopytova, A. E., Izyumchenko, A. D., Kulabukhova, D. G., Silantyev, A. S., Kazakova, V. D., Basharova, K. S., Bezrukova, A. I., Garaeva, L. A., Pichkur, E. B., Artynyuk, A. V., Miliukhina, I. V., Timofeeva, A. A., Miroshnikova, V. V., Naryzhny, S. N., Emelyanov, A. K., Zakharzhevskaya, N. B., Konevega, A. L., Shtam, T. A., & Pchelina, S. N. (2025). p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189152

Vancouver

Usenko TS, Kopytova AE, Izyumchenko AD, Kulabukhova DG, Silantyev AS, Kazakova VD, et al. p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189152

BibTeX
@article{Usenko2025,
  author = {Usenko, Tatiana S and Kopytova, Alena E and Izyumchenko, Artem D and Kulabukhova, Darya G and Silantyev, Artemiy S and Kazakova, Victoria D and Basharova, Katerina S and Bezrukova, Anastasia I and Garaeva, Luiza A and Pichkur, Evgeny B and Artynyuk, Alexandra V and Miliukhina, Irina V and Timofeeva, Alla A and Miroshnikova, Valentina V and Naryzhny, Stanislav N and Emelyanov, Anton K and Zakharzhevskaya, Natalya B and Konevega, Andrey L and Shtam, Tatiana A and Pchelina, Sofya N},
  title = {p.N370S GBA1 Mutation Influences the Morphology and Lipid Composition of Extracellular Vesicles in Blood Plasma from Patients with Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189152}
}
Kostenlos starten →